UPDATE 1-Eli Lilly defeats Teva appeal over Alimta cancer drug
Jan 12 (Reuters) - A U.S. appeals court on Thursday said Eli Lilly and Co may block Teva Pharmaceutical Industries Ltd from selling a generic equivalent of its top-selling lung cancer drug Alimta, in... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: cancer, Alimta, its top-selling, equivalent, generic, selling, Industries Ltd, Pharmaceutical, block, Eli Lilly, court, appeals, (Reuters), appeal, defeats, Lilly, 1-Eli, UPDATE